Parnax Lab

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE383L01019
  • NSEID:
  • BSEID: 506128
INR
112.75
-7.3 (-6.08%)
BSENSE

Dec 05

BSE+NSE Vol: 6.59 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
187.74
188.71
167.61
163.03
89.52
95.31
108.78
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
187.74
188.71
167.61
163.03
89.52
95.31
108.78
Raw Material Cost
93.85
104.74
88.65
91.13
40.41
45.30
43.92
Purchase of Finished goods
0.46
0.15
0.70
0.17
0.36
0.88
9.02
(Increase) / Decrease In Stocks
1.69
-2.07
-0.53
-1.66
0.45
-0.90
-0.22
Employee Cost
24.43
23.72
20.05
17.43
13.68
14.08
13.06
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
-0.01
0.00
0.00
-0.01
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
40.54
38.64
35.76
32.93
24.67
29.53
32.79
Total Expenditure (Excl Depreciation)
160.97
165.17
144.62
140.00
79.57
88.88
98.56
Operating Profit (PBDIT) excl Other Income
26.77
23.54
22.99
23.03
9.95
6.43
10.22
Other Income
1.68
0.82
0.77
0.33
0.21
0.66
2.11
Operating Profit (PBDIT)
28.45
24.36
23.76
23.36
10.16
7.09
12.33
Interest
5.39
5.35
4.95
5.23
5.08
4.60
3.89
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
23.06
19.01
18.81
18.13
5.08
2.49
8.44
Depreciation
7.38
6.96
6.53
5.87
5.16
4.46
3.82
Profit Before Tax
15.67
12.05
12.28
12.26
-0.08
-1.97
4.62
Tax
4.14
2.42
3.65
4.01
0.28
0.95
1.31
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
11.54
9.62
8.63
8.26
-0.36
-2.92
3.31
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
11.54
9.62
8.63
8.26
-0.36
-2.92
3.31
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.02
-0.02
-0.01
-0.02
0.00
0.00
-0.01
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
11.52
9.61
8.62
8.24
-0.36
-2.91
3.30
Equity Capital
11.49
11.49
11.49
9.81
8.50
8.50
8.50
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
71.61
60.09
50.07
38.37
24.04
24.29
27.23
Earnings per share (EPS)
10.03
8.36
7.5
8.4
-0.42
-3.42
3.88
Diluted Earnings per share
10.05
8.38
7.8
9.7
-0.42
-3.43
3.89
Operating Profit Margin (Excl OI)
14.26%
12.47%
13.72%
14.13%
11.11%
6.75%
9.4%
Gross Profit Margin
12.28%
10.07%
11.22%
11.12%
5.67%
2.61%
7.76%
PAT Margin
6.15%
5.1%
5.15%
5.07%
-0.4%
-3.06%
3.04%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -0.51% vs 12.59% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 19.88% vs 11.48% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 13.72% vs 2.39% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 0.75% vs 8.08% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Parnax Lab With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
187.74
0
187.74
Other Operating Income
0.00
0.00
0.00
Total Operating income
187.74
0
187.74
Raw Material Cost
93.85
0
93.85
Purchase of Finished goods
0.46
0
0.46
(Increase) / Decrease In Stocks
1.69
0
1.69
Employee Cost
24.43
0
24.43
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
40.54
0.00
40.54
Total Expenditure (Excl Depreciation)
160.97
0
160.97
Operating Profit (PBDIT) excl Other Income
26.77
0.00
26.77
Other Income
1.68
0
1.68
Operating Profit (PBDIT)
28.45
0
28.45
Interest
5.39
0
5.39
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
23.06
0
23.06
Depreciation
7.38
0
7.38
Profit Before Tax
15.67
0
15.67
Tax
4.14
0
4.14
Provisions and contingencies
0.00
0
0.00
Profit After Tax
11.54
0
11.54
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
11.54
0
11.54
Share in Profit of Associates
0.00
0
0.00
Minority Interest
-0.02
0
-0.02
Other related items
0.00
0.00
0.00
Consolidated Net Profit
11.52
0
11.52
Equity Capital
11.49
0
11.49
Face Value
10.00
0
0.00
Reserves
71.61
0
71.61
Earnings per share (EPS)
10.03
0
10.03
Diluted Earnings per share
10.05
0
10.05
Operating Profit Margin (Excl OI)
14.26%
0%
0.00
14.26%
Gross Profit Margin
12.28%
0%
0.00
12.28%
PAT Margin
6.15%
0%
0.00
6.15%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 187.74 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -0.51% vs 12.59% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 11.52 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 19.88% vs 11.48% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.77 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 13.72% vs 2.39% in Mar 2024

Annual - Interest
Interest 5.39 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 0.75% vs 8.08% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.26%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024